Physician

David A Dalessandro, M.D.

According to 2025 Medicare claims, David Dalessandro, M.D. (NPI: 1538200720) practices cardiology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Luzerne, PA. This provider's primary affiliated billing organization is NORTHEASTERN PENNSYLVANIA CARDIOLOGY ASSOCIATES LLP (NPI: 1043351281; TIN: 232969438) and primary practice location at 18705-1090.

Dalessandro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,606 traditional Medicare patients, billed 6,759 HCPCS/CPT codes, and received $398,453 in Medicare payments. The top billing code was 93306 (Ultrasound of heart with color-depicted blood flow, rate, direction and valve function). Part D data shows 6,881 prescription claims across 935 beneficiaries totaling $992,808 in drug costs, led by Eliquis (Apixaban). 2020 DME data shows 14 claims. Open Payments data shows 113 records totaling $2,023. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $201,988 to $992,808. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $23,463 to $11,477.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,137	7,981	$348,576
2016	1,799	7,451	$337,989
2017	1,480	6,967	$319,475
2018	1,513	10,238	$599,714
2019	1,664	10,361	$599,183
2020	1,747	8,068	$522,650
2021	1,955	7,831	$531,365
2022	1,752	7,084	$459,476
2023	1,673	7,013	$432,784
2024	1,606	6,759	$398,453

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	394	4,893	$201,988
2016	460	5,819	$275,167
2017	475	5,873	$295,381
2018	682	7,415	$453,931
2019	805	8,302	$584,178
2020	832	7,803	$620,076
2021	854	7,662	$751,500
2022	885	7,207	$788,283
2023	863	6,650	$863,761
2024	935	6,881	$992,808

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$23,463
2017	N/R	N/R	N/R
2018	N/R	21	$44,442
2019	N/R	20	$44,896
2020	N/R	14	$31,339
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	537	542	$137
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	610	806	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	739	1,062	$58
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	225	226	$44
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	989	1,936	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	673	28,841	$538,260
Entresto	Sacubitril/Valsartan	128	6,107	$121,588
Xarelto	Rivaroxaban	134	5,812	$104,561
Brilinta	Ticagrelor	80	3,704	$52,660
Repatha Sureclick	Evolocumab	38	1,854	$34,066

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	113	$2,023	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David A. Dalessandro, M.D.?

Tedicare shows public-source Medicare data for David A. Dalessandro, M.D. (NPI 1538200720), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Dalessandro, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David A. Dalessandro, M.D.?

David A. Dalessandro, M.D. is linked to NORTHEASTERN PENNSYLVANIA CARDIOLOGY ASSOCIATES LLP (billing NPI 1043351281) in the available physician profile data.

Does David A. Dalessandro, M.D. have Open Payments data?

David A. Dalessandro, M.D. has 113 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.